Hypoglycemia risk (especially if used with insulin or sulfonylureas in patients with diabetes): monitoring and medication adjustment may be needed
10.3390/antiox11050965 Antioxidants
As of January 2026, only 13 states provided Medicaid coverage for GLP-1 medications for obesity treatment down from 16 states in 2025, largely due to budget pressure from federal funding changes
Please ask your Patient Support agent for more information
Third, the relatively stable insulin levels on keto, compared to the spikes and crashes of a high-carbohydrate reduced-calorie diet, may provide a more favorable hormonal environment for lean tissue preservation
Morville T, Sahl RE, Moritz T, Helge JW, Clemmensen C